Figures computed from official regulatory filings — .
Analysttarget 2 USD (+1999900%) · consensus 3/5 · 0 buy · 1 hold · 0 sell
Ownershipinsiders 0% · institutions 0% · short 1.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NexImmune, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a vivo directly injectable modality platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It also provides NEXI-004 which is in preclinical stage for EBV related diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
25 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Jones Kristi | Buy | $0 | conv 97First in 12mo |
| SEC |
| Roemer Alan S. | Sell | $7.7K | SEC |
| Roemer Alan S. | Sell | $8.3K | SEC |
| Bertram Timothy | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Verstandig Granttrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BARER SOL Jtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| D'Angio Paul | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Yao Zhengbin | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Roemer Alan S. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gandhi Leena | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Jones Kristi | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| D'Angio Paul | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gandhi Leena | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| BARER SOL Jtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| OELKE MATHIAS | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Bertram Timothy | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| OELKE MATHIAS | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| OELKE MATHIAS | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Jones Kristi | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Verstandig Granttrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Roemer Alan S. | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Trainer John | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Trainer John | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Jones Kristi | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| D'Angio Paul | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |